See the Biology of Sepsis –
for the First Time
Learn More:
Learn More:
IntelliSep is a diagnostic tool that risk- stratifies patients based on their probability of having sepsis within the following 3 days post-testing. IntelliSep provides results in around 8 minutes, enabling faster care and optimized patient outcomes.
IntelliSep is an FDA-cleared in vitro diagnostic test for adult patients with signs and symptoms of infection who present to the Emergency Department
All results should be interpreted in the context of the other clinical observations and laboratory test results for the patient
Sepsis is a medical emergency requiring rapid diagnosis and treatment, with an 8% increase in mortality for every hour that treatment is delayed.1
Like heart attack and stroke, now there is an objective detection tool for sepsis.
SECTION HIDDEN
IntelliSep assesses immune activation, and provides a probability of sepsis occurring within 3 days of testing
IntelliSep assesses immune activation and provides a probability of sepsis occurring within 3 days of testing.
Infection is common and most of the time it leads to a regulated immune response, and is self limiting.
However, some infections lead to dysregulated immune response, causing life threatening organ failure. This is sepsis and can lead to long-term morbidity and mortality.
Early diagnosis is key to providing appropriate treatment and achieving source control, leading to better outcomes.
Historically it has been difficult to identify the state of immune activation in real-time, to see who is septic.
Now, with IntelliSep you can, leading to early sepsis detection and the best outcomes.
SOURCE: Graphic adapted from Mervyn Singer, MD, European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2022.
Learn more about how IntelliSep can help your team.
1. The above represents one site’s experience with IntelliSep.